Artificial intelligence model predicts which key of the immune system opens the locks of coronavirus

With an artificial intelligence (AI) method developed by researchers at Aalto University and University of Helsinki, researchers can now link immune cells to their targets and for example uncouple which white blood cells recognize SARS-CoV-2. The developed tool has broad applications in understanding the function of immune system in infections, autoimmune disorders, and cancer.

FDA clears investigational drug for ALS gene therapy trials

Apic Bio, a gene therapy company developing treatment options for patients with rare genetic diseases and co-founded by UMass Medical School’s Robert H. Brown Jr., DPhil, MD, announced that the FDA has cleared its investigational new drug (IND) application for APB-102, a gene therapy candidate designed to treat a common cause of familial amyotrophic lateral …

Newly-discovered molecule provides dual protection against vascular inflammation

A multidisciplinary team of researchers from Duke-NUS Medical School and the Agency for Science, Technology and Research (A*STAR) in Singapore has discovered a new mitochondrial peptide called MOCCI that plays an important role in regulating inflammation of blood vessel and immunity. The study, published in the journal Nature Communications, revealed how one gene encoded two …

After Ellison’s role in Chauvin trial, Democrats look to invest in attorney general races

The role that Minnesota Attorney General Keith Ellison played in the conviction of former police officer Derek Chauvin for murdering George Floyd has given Democrats a potent argument for redoubling the party’s investment in state attorney general races for years to come.

No masks, no social distancing and a 4,000-strong crowd at next month’s Brit Awards, as the UK looks to restart live events

The UK’s flagship music awards ceremony, the Brits, will go ahead with a 4,000-strong crowd, no social distancing and no masks next month, as part of a government trial that offers a peek at how large events can operate in a post-pandemic world.